Gossamer Bio, Inc.GOSSEarnings & Financial Report
Nasdaq
NextMar 13, 2026
GOSS Q3 2025 Key Financial Metrics
Revenue
$13.3M
Gross Profit
N/A
Operating Profit
$-49.1M
Net Profit
$-48.2M
Gross Margin
N/A
Operating Margin
-369.4%
Net Margin
-362.7%
YoY Growth
40.2%
EPS
$-0.21
Financial Flow
Gossamer Bio, Inc. Q3 2025 Financial Summary
Gossamer Bio, Inc. reported revenue of $13.3M for Q3 2025, with a net profit of $-48.2M (-362.7% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $13.3M |
|---|---|
| Net Profit | $-48.2M |
| Gross Margin | N/A |
| Operating Margin | -369.4% |
| Report Period | Q3 2025 |
Gossamer Bio, Inc. Annual Revenue by Year
Gossamer Bio, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $114.7M).
| Year | Annual Revenue |
|---|---|
| 2024 | $114.7M |
Income Statement
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $95.8M | $9.5M | $9.4M | $9.9M | $11.5M | $13.3M |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | -88.0% | 40.2% |
Balance Sheet
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $347.9M | $259.4M | $373.4M | $350.9M | $315.3M | $280.6M | $240.9M | $208.8M |
| Liabilities | $243.3M | $232.6M | $291.9M | $296.7M | $285.8M | $286.8M | $287.0M | $291.2M |
| Equity | $104.6M | $26.7M | $81.5M | $54.1M | $29.5M | $-6.3M | $-46.1M | $-82.3M |
Cash Flow
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-34.5M | $-52.3M | $116.3M | $-32.0M | $-35.5M | $-39.7M | $-47.1M | $-36.2M |